Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

Small aortic annulus poses a major challenge in aortic valve replacement due to the increased risk of prosthesispatient mismatch (PPM) and increased surgical risk. In recent years, transcatheter aortic valve replacement (TAVR) has emerged as a popular alternative to the traditional surgical aortic valve replacement.

Aortic valve 52

Aortic valve Aortic TAVR Myocardial Infarction 52

Heart BMJ

JULY 10, 2024

Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedural planning.

Aortic valve 98

Aortic valve Aortic Quality of Life TAVR 98

DAIC

JANUARY 29, 2024

Getty Images milla1cf Mon, 01/29/2024 - 14:24 January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under age 65 with severe aortic stenosis , many hospitals are still opting for a nonsurgical approach in patients under 60—possibly with poorer survival rates.

Aortic valve 111

Aortic valve TAVR Aortic Outcomes 111

Open Heart

FEBRUARY 27, 2024

Objectives The clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active cancer remain insufficiently explored. This study aimed to assess the midterm outcomes of TAVR in patients diagnosed with AS and active cancer.

Aortic valve 98

Aortic valve Cancer Aortic TAVR 98

Society of Thoracic Surgeons - Adult Cardiac

JANUARY 26, 2025

Shettys team followed 252 patients who underwent the Ross procedure, a heart valve replacement operation commonly used to treat younger patients with severe aortic valve disease. Congenital All Members Clinical Decision-Making Patient Outcomes Quality Improvement

Aortic valve 83

Aortic valve Cardiothoracic Congenital Aortic 83

Cardiology Update

FEBRUARY 26, 2024

Transcatheter aortic valve replacement (TAVR) is the standard treatment for severe aortic stenosis, but post-TAVR leaflet thrombus, identified by hypoattenuated leaflet thickening (HALT), poses potential risks like cerebral thromboembolic events. had thrombus at any aortic valve complex. Specifically, 14.2%

TAVR 122

TAVR Aortic valve Outcomes Aortic 122

JAMA Cardiology

OCTOBER 29, 2024

This cohort study assesses characteristics and outcomes of younger patients undergoing transcatheter aortic valve replacement.

Aortic valve 65

Aortic valve Aortic Outcomes 65

JAMA Cardiology

MAY 14, 2024

This cohort study examines whether there is an association between osteosarcopenia and adverse outcomes, such as increased risk of mortality, in older adults following transcatheter aortic valve replacement (TAVR).

Aortic valve 75

Aortic valve Aortic TAVR Outcomes 75

Frontiers in Cardiovascular Medicine

MARCH 28, 2025

This study aimed to evaluate the early and mid-term outcomes of transcatheter closure using a double-disc occluder device in a single-center Vietnamese cohort.MethodA prospective descriptive study was conducted at Hanoi Heart Hospital, Vietnam. Data were analyzed using SPSS 20.0.ResultsThe

VSD 52

VSD Outcomes Congenital Heart Disease Aortic valve 52

Cardiology Update

JANUARY 28, 2024

The optimal management of concomitant chronic obstructive coronary artery disease (CAD) in transcatheter aortic valve replacement (TAVR) recipients remains a debated topic. Major outcomes included procedural all-cause mortality and complications, major adverse cardiovascular events, and post-TAVR unplanned coronary revascularization.

TAVR 115

TAVR Aortic valve Outcomes Coronary Artery Disease 115

Frontiers in Cardiovascular Medicine

JANUARY 2, 2024

Bicuspid aortic valve (BAV) is a common congenital heart condition that can lead to some valve-related complications, such as aortic stenosis and/or regurgitation, and is often associated with aortic root dilation.

Aortic valve 64

Aortic valve Bicuspid/Mitral Aortic Outcomes 64

Heart BMJ

MARCH 26, 2025

2 Therefore, early identification of HF in high-risk populations, particularly post-MI, is essential for improving outcomes. Heart failure (HF) is one of the significant complications in patients with myocardial infarction (MI), leading to increased risk for cardiovascular morbidity and mortality.

Myocardial Infarction 52

Myocardial Infarction Preserved Ejection Fraction Heart Failure Aortic valve 52

American College of Cardiology

FEBRUARY 12, 2024

The goal of the NOTION trial was to compare outcomes after transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in unselected patients with severe degenerative aortic stenosis.

Aortic valve 56

Aortic valve Aortic TAVR Stenosis 56

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 15:39 March 30, 2025 Medtronic has announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Two-Year Outcomes of the Five-Year SMART Trial, presented at CRT 2025. Additional findings at five years include: Numerically lower rate of cardiovascular mortality (7.2% Evolut TAVR vs. 9.3%

TAVR 52

TAVR Stenosis Aortic Outcomes 52

Journal of Cardiothoracic Surgery

JULY 30, 2024

With the introduction of transcatheter aortic valve implantation, the role of surgical aortic valve replacement (SAVR) in elderly patients has been called into question. We investigated the short-term outcomes.

Aortic valve 52

Aortic valve Aortic Outcomes Research 52

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

This study aims to identify risk factors for conduction disturbances in such patients using a specific fluoroscopic cusp overlap (COL) technique.MethodsThis retrospective study analyzed AS patients who underwent TAVR with SEV from 2019 to 2022, excluding those needing pacemakers or valve-in-valve procedures.

Pacemaker 52

Pacemaker Aortic Stenosis Aortic valve 52

Circulation: Cardiovascular Interventions

DECEMBER 28, 2023

BACKGROUND:A high permanent pacemaker implantation (PPI) risk remains a concern of self-expandable transcatheter aortic valve implantation, despite the continued improvements in implantation methodology. There were no group differences in 30-day all-cause mortality (1.4% versus 0%;P=0.608).CONCLUSIONS:Our

Aortic valve 76

Aortic valve Aortic Pacemaker Cardiovascular Interventions 76

Journal of Cardiothoracic Surgery

APRIL 19, 2024

Patients with severe aortic stenosis (AS) and left ventricular (LV) dysfunction demonstrate improvement in left ventricular injection fraction (LVEF) after aortic valve replacement (AVR). The timing and magnit.

Aortic valve 52

Aortic valve Aortic Stenosis Outcomes 52

NEJM Journal Watch - Cardiology

FEBRUARY 22, 2024

Ten-year follow-up of an “all-comers” randomized trial demonstrates no difference in clinical outcomes between TAVR and SAVR.

Aortic valve 75

Aortic valve TAVR Outcomes Aortic 75

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Transcatheter aortic valve replacement (TAVR) is a relatively new treatment method for aortic stenosis (AS) and has been demonstrated to be suitable for patients with varying risk levels.

Aortic valve 64

Aortic valve Cardiac Rehabilitation Aortic TAVR 64

JAMA Cardiology

MAY 21, 2024

This cohort study evaluates mortality and morbidity outcomes among patients undergoing transcatheter or surgical replacement for failed bioprosthetic aortic valves.

Aortic valve 51

Aortic valve Aortic Outcomes 51

Med Page Today

MARCH 29, 2025

(MedPage Today) -- CHICAGO -- Dapagliflozin (Farxiga) lowered mortality and heart failure worsening in high-risk older adults getting transcatheter aortic valve implantation (TAVI), the DapaTAVI trial showed. In a population with a history of.

Aortic valve 69

Aortic valve Outcomes Heart Failure Aortic 69

Journal of Cardiothoracic Surgery

AUGUST 23, 2024

Surgical aortic valve replacement (SAVR) is an established therapy for severe calcific aortic stenosis. Enhanced recovery after cardiac surgery (ERACS) protocols have been shown to improve outcomes for electiv.

Aortic valve 52

Aortic valve COVID-19 Aortic Stenosis 52

Open Heart

AUGUST 10, 2023

Objectives Assessment of frailty prior to aortic valve intervention is recommended in European and North American valvular heart disease guidelines. Methods Nine electronic databases were searched systematically for data on clinical outcomes post-TAVI/SAVR, where patients had undergone preoperative frailty assessment using the CFS.

Aortic valve 52

Aortic valve Aortic Outcomes Heart Disease 52

Open Heart

MARCH 29, 2024

Background Aortic stenosis is a life-limiting condition for which transcatheter aortic valve implantation (TAVI) is an established therapy. Subsidiary outcomes included patient angina and breathlessness scores. After multivariate analysis, the presence of CAD had no effect on the primary outcome (HR 0.98, CI 0.68

Coronary Artery Disease 52

Coronary Artery Disease Aortic valve Aortic Outcomes 52

Frontiers in Cardiovascular Medicine

OCTOBER 8, 2024

Patient selection was based on the presence of isolated aortic valve disease without the need for ascending aorta replacement or aortic root enlargement. The majority of patients (77.1%) presented with aortic stenosis, often accompanied by severe calcification. Peripheral cardiopulmonary bypass (CPB) was established.

Aortic valve 52

Aortic valve Aortic Stenosis Outcomes 52

DAIC

APRIL 30, 2024

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Outcomes were worse with increasing surgical urgency, older age, dialysis dependence, and multiple reoperations.

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

Journal of the American Heart Association

APRIL 10, 2025

BackgroundBicuspid aortic valves are associated with ascending aortic pathology, but their impact on longterm outcomes, including aortic growth and adverse events, remains unclear.Methods and ResultsThis prospective cohortstudy included adult patients undergoing aortic valve surgery or ascending aortic surgery at a single center (20072013).

Aortic valve 45

Aortic valve Aortic Bicuspid/Mitral Tricuspid 45

DAIC

MARCH 14, 2025

tim.hodson Fri, 03/14/2025 - 16:12 SCAI Scientific Sessions 2025 will take place May 1 to 3, attheWalter E. Washington Convention Center in Washington, DC.

TAVR 52

TAVR Aortic valve Peripheral Arterial Disease Embolism 52

Open Heart

APRIL 27, 2023

Background and aims Randomised controlled trials comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) were performed in highly selected populations and data regarding long-term secondary complications beyond mortality are scarce.

Aortic valve 52

Aortic valve TAVR Aortic Outcomes 52

Open Heart

JANUARY 19, 2025

Aim This study aimed to systematically review and analyse the existing evidence on outcomes of emergency transcatheter aortic valve implantation (eTAVI) and emergency balloon aortic valvuloplasty (eBAV) in CS patients. Despite advancements in emergency interventions, the optimal treatment approach remains uncertain.

Cardiogenic Shock 52

Cardiogenic Shock Aortic Stenosis Aortic valve 52

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). Circulation: Cardiovascular Interventions, Ahead of Print. Poverall=0.765; 1 year: 1.4%

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

Journal of Cardiothoracic Surgery

APRIL 11, 2025

to document the Egyptian experience with Ozaki procedure in adults and children and compare the clinical outcomes of the procedure to that of aortic valve replacement (AVRc) in adult patients.

Aortic valve 40

Aortic valve Aortic Pediatrics Document 40

Becker's Hospital Review - Cardiology

DECEMBER 8, 2023

After bioprosthetic aortic valve replacement, patients who took the oral drug warfarin had better outcomes including lower mortality rates and fewer blood clots, according to new research from Rochester, Minn.-based based Mayo Clinic.

Aortic valve 49

Aortic valve Aortic Blood Clot Research 49

Frontiers in Cardiovascular Medicine

OCTOBER 24, 2024

ConclusionAortic valve replacement with the Perceval S valve through either an upper hemisternotomy or a right anterior thoracotomy is a procedure associated with low perioperative complication rates. This was a retrospective, single-center observational study. ResultsThe overall in-hospital mortality was 1,7%.

Aortic valve 52

Aortic valve Aortic Atrial Fibrillation Pacemaker 52

Journal of Cardiothoracic Surgery

JULY 15, 2024

New prosthetic valves and surgical approaches that shorten operation time and improve the outcome of patients with aortic valve (AV) infective endocarditis (IE) and AV insufficiency (AVI) are crucial. The aim.

Aortic valve 40

Aortic valve Aortic Outcomes Research 40

The American Journal of Cardiology

DECEMBER 13, 2023

Publication date: Available online 8 December 2023 Source: The American Journal of Cardiology Author(s): Michel Pompeu Sá, Xander Jacquemyn, Derek Serna-Gallegos, Amber Makani, Dustin Kliner, Catalin Toma, David West, Danial Ahmad, Sarah Yousef, James A. Brown, Pyongsoo Yoon, David Kaczorowski, Johannes Bonatti, Danny Chu, Ibrahim Sultan

Aortic valve 75

Aortic valve Aortic Outcomes 75